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Purpose: To prospectively evaluate the diurnal variation of intraocular pressure (IOP) during 
unoprostone treatment in 13 healthy volunteers.
Method: IOP was measured by Goldmann applanation tonometry by the same observer every 
3 hours from 9 am to 9 am the next morning. Unoprostone was then instilled at 9 am and 9 pm 
daily for 1 month. After 1 month, IOP was measured again with unoprostone instilled at 9 am 
and 9 pm during IOP measurement. We then compared the average daily IOP before and after 
the treatment (paired t-test).
Results: After 1 month of treatment, the average IOP decreased at every time point but one 
(12 pm, 3 pm, 6 pm, 9 pm, 12 am, 3 am, and 9 am, but not at 6 am). There were no adverse 
reactions and none of the subjects discontinued unoprostone.
Conclusion: The hypotensive effects of unoprostone persist throughout the day, but this study 
suggests that the effects may be weaker at nighttime and early in the morning.
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Introduction
There are diurnal variations of intraocular pressure (IOP). So we must consider not 
only IOP values during the daytime but also nighttime when selecting glaucoma 
  eyedrops. Unoprostone isopropyl (unoprostone) reduces IOP due to increased uveo-
scleral outflow.1 There are few reports on the diurnal variations of IOP with unoprostone 
treatment.2–4 The purpose of this study was to prospectively evaluate diurnal variations 
in IOP after unoprostone treatment.
Methods
The study included 13 healthy volunteers (six men and seven women) with 26 eyes 
without ocular disease except for abnormal refraction. The mean age ± SD (range) 
of the subjects was 33.6 ± 8.5 years (22–48 years). Refraction was −1.8 ± 2.0 D 
(−4.75 to 0.75 D). The IOP was measured by Goldmann applanation tonometry by the 
same observer every 3 hours over a 24 hour period from 9 am to 9 am (next morning). 
Before measurements, the examinees sat down quietly for more than 5 minutes. 
Drinking alcohol, vigorous exercise, smoking, and drinking large amounts of water 
(more than 1 L) were prohibited. During the study period of 1 month, subjects worked 
from 9 am–6 pm, ate dinner and took some rest (watched TV , or undertook other rec-
reational activities) from 6 pm–9 am, and slept from 9 pm–9 am. Unoprostone was 
instilled daily at 9 am and 9 pm in both eyes for 1 month. One month after treatment, Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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IOP was remeasured over a 24 hour period, with a drop of 
unoprostone being instilled at 9 am and 9 pm on the day of 
IOP measurement.
The average IOP was analyzed using a paired t-test 
to compare pre- and post-treatment values. A P value of 
0.05 was used to declare significance. The reduction rate 
of IOP was calculated at every time point. Adverse reac-
tions were evaluated before and after 1 month of treatment. 
The subjects signed an informed consent document before 
participation.
Results
The average IOP after 1 month of treatment (13.1 ± 1.6 mmHg) 
was significantly decreased compared with that before treat-
ment (14.0 ± 1.7 mmHg, P , 0.05). The average IOP at 
each time point after 1 month of treatment was significantly 
decreased compared with that before treatment, except at 
6 am, where the value increased slightly but not statisti-
cally significantly (Figure 1). The reductions in IOP from 
baseline were: 4.0% ± 15.1% at 9 am, 5.4% ± 14.6% at 
12 pm, 11.2% ± 16.2% at 3 pm, 5.4% ± 9.7% at 6 pm, 
8.4% ± 10.1% at 9 pm, 5.3% ± 13.8% at 12 am, 7.7% ± 16.4% 
at 3 am, −3.6% ± 16.6% at 6 am, and 6.9% ± 13.9% at 9 am 
the next morning (Figure 2). Adverse reactions were not 
observed, and no one discontinued use of unoprostone.
Discussion
Takase et al reported that after instilling unoprostone as a 
single dose into eleven healthy volunteer’s eyes, the IOP 
decreased significantly 2 and 5 hours after instillation, 
and the reduction value in IOP was 1.3–3.3 mmHg.2 In 
this study, the change in IOP was from –1.7 to 0.3 mmHg 
when measured every 3 hours; it is unknown why our 
results were lower in value. Stewart et al reported that 
IOP decreased significantly after daily instillation of 
unoprostone over 2 weeks in 24 patients with primary 
open-angle glaucoma (POAG) or ocular hypertension, 
and the IOP changed from 23.4 +/− 2.0 mmHg at base-
line to 19.3 +/− 4.4 mmHg.3 In a study by Araie et al,4 on 
POAG or ocular hypertension in ten eyes of five patients, 
unoprostone was instilled into the eyes daily for 4 weeks. 
The IOP was measured every 2 hours from 9 am to 9 pm 
before and after instillation and results were compared. 
Measurements were not taken during the night in Araie’s 
study. The IOP decreased significantly at 9 am, 11 am, 
5 pm, 7 pm, and 9 pm and the reduction in IOP was 
1.3 to 3.7 mmHg 4 weeks after treatment. In our study, 
the lesser reductions obtained may be because the IOP 
before treatment (14.0 ± 1.7 mmHg) was lower than that 
in Stewart’s study (23.4 ± 2.0 mmHg)3 and Araie’s study 
(22.7 ± 0.5 mmHg).4 The IOP decreases in our study were 
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Figure 1 Intraocular pressure before and 1 month after treatment.
Note: *P , 0.05, paired t-test.Clinical Ophthalmology
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significant (P , 0.05) except at 9 am the first day and 6 
am the next morning, suggesting that unoprostone acts to 
reduce IOP throughout the day. However there is a possi-
bility that the hypotensive effect of unoprostone weakens 
at night and in the early morning.
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